Analyst consensus rating
Altimmune Analyst Rating: Strong Buy
Direct answer
Altimmune's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.67.
Forecast evidence checked November 14, 2026.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.65
- Average price target
- $16.67
- High price target
- $26.00
- Low price target
- $11.00
- Low target gap
- +568.7%
- Target upside
- +913.2%
- High target gap
- +1,480.5%
- Target range width
- 911.9%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Altimmune?
Altimmune has a verified Strong Buy consensus. The same dataset has an average price target of $16.67.
How far are Altimmune's low and high targets from the recorded price?
The low target implies +568.7%, while the high target implies +1,480.5%.
How many analysts are included in Altimmune's consensus?
The verified consensus includes 9 analysts.
How is Altimmune's target upside or downside calculated?
The average target of $16.67 is divided by the recorded price of $1.65, then one is subtracted to produce +913.2%. This does not guarantee a future return.
When was Altimmune's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.